Index Performance
+14.98%
SYNB
Overview
Description
SynBio market (incl. biomedical, bioservices & bioprocess, food & agriculture, industrial bioproducts & ingredients, biotools & reagents) is booming.
- TickerSYNB
- Inception Date01/13/2023
- WeightingMarket Cap
- # of holdings94
What's inside?
Holdings
All holdings as of July 26, 2024
CSV download
| Moderna, Inc. (MRNA) | 23.35% | $46.14B | -91.07% | 20.96% | 6.49 |
| Alnylam Pharmaceuticals, Inc. (ALNY) | 13.98% | $30.09B | 54.82% | 86.65% | 9.57 |
| BioNTech SE (BNTX) | 10.27% | $20.13B | -85.14% | 68.50% | 4.32 |
| BioMarin Pharmaceutical, Inc. (BMRN) | 8.04% | $16.25B | 9.61% | 78.54% | 7.05 |
| Sarepta Therapeutics, Inc. (SRPT) | 5.19% | $13.95B | 63.10% | 85.66% | 9.14 |
| Ionis Pharmaceuticals, Inc. (IONS) | 3.63% | $7.57B | -8.45% | 93.47% | 7.81 |
| CRISPR Therapeutics AG (CRSP) | 2.58% | $4.89B | -99.50% | -10,177.58% | 13.62 |
| BridgeBio Pharma, Inc. (BBIO) | 2.48% | $5.00B | 11,461.88% | 99.10% | 30.87 |
| Avidity Biosciences, Inc. (RNA) | 2.20% | $4.28B | 58.67% | 81.91% | 121.34 |
| Ultragenyx Pharmaceutical, Inc. (RARE) | 1.93% | $4.08B | 8.30% | 75.76% | 10.05 |
| ImmunityBio, Inc. (IBRX) | 1.72% | $3.80B | -88.89% | -11,287.50% | 14,367.70 |
| Genscript Biotech Corp. (1548) | 1.70% | $3.46B | 34.15% | 48.78% | 5.32 |
| Arcellx, Inc. (ACLX) | 1.66% | $3.35B | 119.16% | 97.90% | 24.17 |
| Arrowhead Pharmaceuticals, Inc. (ARWR) | 1.62% | $3.59B | -100.00% | N/A | 96.25 |
| Twist Bioscience Corp. (TWST) | 1.60% | $3.35B | 25.13% | 41.01% | 6.41 |
| Amicus Therapeutics, Inc. (FOLD) | 1.45% | $3.04B | 27.97% | 85.76% | 8.91 |
| Beam Therapeutics, Inc. (BEAM) | 1.36% | $2.65B | -69.39% | 26.71% | 4.91 |
| Iovance Biotherapeutics, Inc. (IOVA) | 1.28% | $2.64B | N/A | -1,653.15% | 1,929.39 |
| Intellia Therapeutics, Inc. (NTLA) | 1.26% | $2.55B | 129.53% | 91.32% | 37.01 |
| PTC Therapeutics, Inc. (PTCT) | 1.18% | $2.57B | -4.66% | 68.46% | 1.90 |
| 10X Genomics, Inc. (TXG) | 1.08% | $2.10B | 5.01% | 67.78% | 6.72 |
| Oxford Nanopore Technologies Plc (ONT) | 0.75% | $1.51B | -14.57% | 42.43% | 8.89 |
| Sana Biotechnology, Inc. (SANA) | 0.67% | $1.34B | N/A | N/A | N/A |
| Maravai Lifesciences Holdings, Inc. (MRVI) | 0.58% | $1.13B | -18.79% | 29.57% | 5.53 |
| 4D Molecular Therapeutics, Inc. (FDMT) | 0.46% | $957.55M | -90.60% | -5,592.86% | 51.06 |
| CureVac NV (CVAC) | 0.41% | $816.47M | 75.57% | -269.85% | 6.25 |
| Wave Life Sciences Ltd. (WVE) | 0.39% | $771.59M | -3.02% | 82.64% | 5.80 |
| Arbutus Biopharma Corp. (ABUS) | 0.35% | $739.77M | -77.09% | 76.83% | 25.56 |
| REGENXBIO, Inc. (RGNX) | 0.35% | $708.79M | -18.37% | 45.83% | 9.17 |
| CanSino Biologics, Inc. (CASBF) | 0.34% | $683.59M | 8.16% | 58.84% | 4.68 |
| Arcturus Therapeutics Holdings, Inc. (ARCT) | 0.31% | $618.89M | -59.11% | 97.23% | 5.24 |
| Ginkgo Bioworks Holdings, Inc. (DNA) | 0.30% | $582.26M | -52.98% | 41.83% | 8.22 |
| Verve Therapeutics, Inc. (VERV) | 0.30% | $628.06M | 305.63% | 71.34% | 35.60 |
| Allogene Therapeutics, Inc. (ALLO) | 0.30% | $607.56M | -57.69% | -16,059.09% | 3,592.23 |
| PepGen Inc. (PEPG) | 0.29% | $584.16M | N/A | N/A | N/A |
| Fate Therapeutics, Inc. (FATE) | 0.29% | $614.69M | -96.74% | -150.44% | 71.11 |
| Entrada Therapeutics, Inc. (TRDA) | 0.28% | $634.85M | 134.05% | 98.42% | 1.42 |
| Oxford Biomedica Plc (OXB) | 0.25% | $472.18M | -36.04% | 43.78% | 2.50 |
| Absci Corp. (ABSI) | 0.24% | $495.31M | -29.24% | -280.40% | 74.98 |
| Voyager Therapeutics, Inc. (VYGR) | 0.24% | $499.88M | -87.03% | 93.87% | 1.51 |
| Editas Medicine, Inc. (EDIT) | 0.23% | $458.07M | -88.48% | -24.14% | 4.98 |
| Precigen, Inc. (PGEN) | 0.21% | $419.02M | -42.46% | -76.10% | 59.44 |
| uniQure NV (QURE) | 0.20% | $416.07M | 59.34% | -39.72% | 12.55 |
| Carbios SA (ALCRB) | 0.19% | $373.75M | -65.71% | N/A | 10,249.20 |
| Poseida Therapeutics, Inc. (PSTX) | 0.18% | $350.02M | 172.09% | 95.10% | 2.33 |
| Solid Biosciences, Inc. (SLDB) | 0.17% | $347.33M | N/A | N/A | N/A |
| MeiraGTx Holdings Plc (MGTX) | 0.16% | $327.32M | -79.09% | -369.87% | 31.46 |
| Codexis, Inc. (CDXS) | 0.12% | $257.54M | 31.51% | 64.23% | 2.71 |
| 2seventy Bio, Inc. (TSVT) | 0.12% | $234.92M | -70.12% | 46.88% | 4.92 |
| Caribou Biosciences, Inc. (CRBU) | 0.11% | $220.38M | -30.64% | 70.77% | 5.77 |
| Generation Bio Co. (GBIO) | 0.11% | $227.53M | N/A | 67.68% | 14.54 |
| bluebird bio, Inc. (BLUE) | 0.11% | $231.29M | 720.13% | N/A | N/A |
| Calyxt, Inc. (CLXT) | 0.10% | $207.00M | 1,197.62% | -224.22% | 294.03 |
| Abeona Therapeutics, Inc. (ABEO) | 0.10% | $206.04M | N/A | N/A | 45.29 |
| Graphite Bio, Inc. (GRPH) | 0.10% | $611.24M | N/A | N/A | N/A |
| Sangamo Therapeutics, Inc. (SGMO) | 0.09% | $139.45M | -99.70% | -425.16% | 5.14 |
| Adverum Biotechnologies, Inc. (ADVM) | 0.08% | $167.92M | -100.00% | N/A | N/A |
| Aemetis, Inc. (AMTX) | 0.08% | $149.18M | 3,276.75% | -0.84% | 2.64 |
| Cellectis SA (ALCLS) | 0.08% | $139.88M | 3,120.31% | -0.91% | 32.81 |
| ProQR Therapeutics NV (PRQR) | 0.08% | $153.93M | 587.25% | 84.47% | 8.51 |
| Gevo, Inc. (GEVO) | 0.07% | $142.94M | -1.72% | -103.36% | -0.90 |
| Capricor Therapeutics, Inc. (CAPR) | 0.07% | $141.67M | 64.29% | 93.25% | 6.58 |
| Adicet Bio, Inc. (ACET) | 0.06% | $124.08M | N/A | N/A | N/A |
| Kraig Biocraft Laboratories, Inc. (KBLB) | 0.06% | $114.84M | N/A | N/A | N/A |
| Regulus Therapeutics, Inc. (RGLS) | 0.06% | $115.22M | N/A | N/A | N/A |
| Benitec Biopharma, Inc. (BNTC) | 0.04% | $85.53M | -100.00% | N/A | -9.50 |
| Agronomics Ltd. (AGNMF) | 0.04% | $76.63M | -100.00% | N/A | N/A |
| Precision BioSciences, Inc. (DTIL) | 0.04% | $70.43M | 100.27% | 91.88% | -0.66 |
| Vor Biopharma, Inc. (VOR) | 0.03% | $64.96M | N/A | N/A | N/A |
| AVROBIO, Inc. (AVRO) | 0.03% | $65.98M | N/A | N/A | N/A |
| Passage Bio, Inc. (PASG) | 0.03% | $54.24M | N/A | N/A | N/A |
| Atara Biotherapeutics, Inc. (ATRA) | 0.03% | $47.87M | 2,131.40% | 92.74% | 4.14 |
| Dyadic International, Inc. (DYAI) | 0.02% | $41.22M | -65.79% | 56.98% | 18.65 |
| Vascular Biogenics Ltd. (VBLT) | 0.02% | N/A | -14.32% | N/A | -17.03 |
| Percheron Therapeutics Ltd. (ATHJF) | 0.02% | $43.79M | N/A | N/A | N/A |
| MediGene AG (MDG1) | 0.02% | $37.58M | -80.69% | 49.40% | 3.93 |
| Gensight Biologics SA (GSGTF) | 0.02% | $35.70M | -50.93% | N/A | 30.40 |
| Evogene Ltd. (EVGN) | 0.01% | $24.58M | 577.68% | 76.59% | N/A |
| Celyad Oncology SA (CYAD) | 0.01% | $11.87M | N/A | 871.57% | 203.10 |
| Mustang Bio, Inc. (MBIO) | <0.01% | $12.03M | N/A | N/A | N/A |
| Senti Biosciences, Inc. (SNTI) | <0.01% | $10.62M | -100.00% | N/A | 23.72 |
| Cult Food Science Corp. (CULT) | <0.01% | $7.88M | N/A | N/A | N/A |
| Evolva Holding SA (EVE) | <0.01% | $7.84M | 57.32% | N/A | 6.29 |
| Willow Biosciences, Inc. (CANSF) | <0.01% | $9.92M | -81.39% | -590.20% | 13.63 |
| Sorrento Therapeutics, Inc. (SRNE) | <0.01% | $6.01M | 18.78% | N/A | 7.21 |
| AquaBounty Technologies, Inc. (AQB) | <0.01% | $6.29M | 19.96% | -958.49% | 5.40 |
| BacTech Environmental Corp. (BAC) | <0.01% | $6.04M | N/A | N/A | N/A |
| Alaunos Therapeutics, Inc. (TCRT) | <0.01% | $6.04M | N/A | -100.00% | 4,139.61 |
| Bio-Path Holdings, Inc. (BPTH) | <0.01% | $3.69M | N/A | N/A | N/A |
| Arcadia Biosciences, Inc. (RKDA) | <0.01% | $3.90M | -16.83% | 34.66% | -0.89 |
| Phio Pharmaceuticals Corp. (PHIO) | <0.01% | $1.96M | N/A | N/A | N/A |
| Atlantic International Corp. (SQL) | <0.01% | $268.01M | N/A | N/A | N/A |
| Eat & Beyond Global Holdings, Inc. (EATS) | <0.01% | $1.05M | 413.89% | 100.00% | -101.89 |
| Yield10 Bioscience, Inc. (YTEN) | <0.01% | $1.02M | 400.00% | 78.00% | 20.52 |
Market data by FactSet
